ALI SYED
Dentist at Euclid Ave, Cleveland, OH

License number
Ohio 71.000243
Category
Dentist
Type
Dentist
Address
Address
10900 Euclid Ave, Cleveland, OH 44106
Phone
(216) 368-3200

Professional information

Ali Syed Photo 1

Vp Finance/Cfo

Position:
Vice President/Chief Financial Officer at YMCA of Greater
Location:
Cleveland/Akron, Ohio Area
Industry:
Nonprofit Organization Management
Work:
YMCA of Greater since Jun 2011 - Vice President/Chief Financial Officer YMCA of Metropolitan Washington, District of Columbia Sep 2008 - Jun 2011 - Vice President YMCA of South Oct 2004 - May 2007 - Chief Financial Officer Family YMCA Sep 1999 - Sep 2004 - CFO Madison Area YMCA Jan 1999 - Jan 2003 - Chief Financial Officer CFO Dec 1996 - Sep 1999 - Operations Director Anchorage Community YMCA Jan 1995 - Jan 1997 - Interim Executive/Chief Financial Officer
Education:
DeSales University 2003 - 2006
Master of Business Administration (MBA), Finance and Financial Management Services
Northwestern State University 1987 - 1989
BS, Business Administration/Finance
Skills:
Managerial Finance, Financial Analysis, Budgets, Accounting, Fundraising, Strategic Planning, Financial Reporting, Non-profits, General Ledger, Forecasting, Leadership, Accounts Receivable


Ali Syed Photo 2

Novel Alicyclic Imidazoles As H3 Agents

US Patent:
2002004, Apr 11, 2002
Filed:
Aug 15, 2001
Appl. No.:
09/930644
Inventors:
Yajing Rong - Monmonth Jct NJ, US
Jack Jiang - Orange Village OH, US
Ali Syed - Solon OH, US
International Classification:
A61K031/675, A61K031/4164, A61K031/4178, C07D233/58
US Classification:
514/094000, 514/396000, 514/397000, 548/311100, 548/335100, 548/112000
Abstract:
Alicyclic imidazole compounds; pharmaceutically active compositions containing such compounds; and the use of such compounds in formulations for the control or prevention of disease states in which histamine Hreceptors are involved, such as allergy, inflammation, hypotension, glaucoma, sleeping disorders, states of hyper- and hypo-motility of the gastro-intestinal tract, cardiovascular disease, hypo- and hyper-activity of the central nervous system, Alzheimer's, schizophrenia, obesity and migraines are disclosed.